methoxyhydroxyphenylglycol has been researched along with amyloid beta-peptides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andree, TH; Gong, X; Liu, F; Marquis, K; Reinhart, P; Zhang, G | 1 |
| Aerts, T; Coppus, AM; De Deyn, PP; Dekker, AD; Kremer, BP; Naudé, PJ; Van Dam, D; van Duijn, CM; Vermeiren, Y | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and amyloid beta-peptides
| Article | Year |
|---|---|
The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
Topics: Amyloid beta-Peptides; Animals; Benzoates; Cells, Cultured; Chromones; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; In Vitro Techniques; Indoles; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Morpholines; Neurons; Oncogene Protein v-akt; Peptide Fragments; Phosphorylation; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Serine; Signal Transduction | 2005 |
Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Disease Progression; Dopamine; Down Syndrome; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Peptide Fragments | 2015 |